Following is a list of a few stocks that witnessed notable price movements during Wednesday’s trading session, following significant bulk and block deal transactions executed on the stock exchanges on 10th and 11th June. These fluctuations reflect investor sentiment and market reactions to the large-scale buying or selling activities observed during the period.
1. AU Small Finance Bank Limited
With a market cap of Rs. 57,708.6 crores, the stock moved up by nearly 2 percent on BSE, rising to Rs. 778.55 on Wednesday. As per the latest bulk deal, foreign investor TA FDI Investors Limited offloaded around 93.9 lakh equity shares, representing a 1.26 percent stake in AU Small Finance Bank, via an open market transaction on BSE. The transaction was valued at nearly Rs. 713.7 crores, executed at an average price of Rs. 760.07 per share.
AU Small Finance Bank Limited is engaged in providing a range of banking and financial services, including retail banking, wholesale banking and treasury operations and other services.
2. Generic Engineering Construction & Projects Limited
With a market cap of Rs. 242 crores, the stock moved up by nearly 4 percent on BSE, rising to Rs. 47 on Wednesday. As per the latest bulk deal, Ascent Wealth purchased around 3.2 lakh equity shares, representing a 0.56 percent stake in Generic Engineering, via an open market transaction on NSE. The transaction was valued at nearly Rs. 1.5 crores, executed at an average price of Rs. 46.61 per share.
Generic Engineering Construction and Projects Limited is engaged in the construction of residential, industrial, commercial and Institutional buildings, offering general contracting, design-build, EPC, and project management consultancy (PMC) services.
With a market cap of Rs. 11,938.6 crores, the stock moved up by nearly 7.5 percent on BSE, rising to Rs. 268.75 on Wednesday.A total of 1.02 crore shares changed hands in the block deal, at an average price of Rs. 250 each. The overall transaction value is estimated at Rs. 257 crore.
According to sources, foreign investor OrbiMed Asia IV Mauritius FVCI Limited planned to offload a 2.27 percent stake in the company through the block deal, amounting to Rs. 256.8 crore.
As per the latest shareholding pattern with the BSE, OrbiMed held a 10.88 percent stake prior to the transaction. Post-deal, its shareholding is expected to decline to 8.61 percent.
Marksans Pharma Limited is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centres, one located in Goa and the other in Navi Mumbai.
4. Aditya Birla Capital Limited
With a market cap of Rs. 64,496 crores, the stock moved up by nearly 3.4 percent on BSE, rising to hit a new 52-week high at Rs. 250.95 on Wednesday.
On 11th June, a block deal involving 2.34 crore equity shares equivalent to 0.9 percent of Aditya Birla Capital’s equity was executed at a price of Rs. 242.65 per share, amounting to a total transaction value of nearly Rs. 568 crore.
According to sources, Jomei Investments, a special purpose vehicle (SPV) backed by Advent International Corporation, had initiated the block deal on 10th June to divest a 1.4 percent stake in the company for nearly Rs. 856 crore. The floor price for the transaction was set at Rs. 237.8 per share.
Aditya Birla Capital Limited is principally engaged in the business of financial services, including lending, both as a non-banking financial institution and as a housing finance institution, life and health insurance, asset management, general insurance, stock broking and others.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
